CC

CMEA Capital

North America, California, United States, San Francisco

Description

CMEA Capital was a prominent venture capital firm established in 1989 and headquartered in San Francisco, California. Over its operational history, the firm primarily concentrated on early-stage technology companies across diverse sectors, including information technology, life sciences, and clean energy. CMEA Capital aimed to identify and nurture innovative startups with high growth potential, providing crucial early-stage capital and strategic guidance to help them scale within their respective markets.

The firm successfully raised a substantial amount of capital, totaling over $1.2 billion across eight distinct venture funds. Its final fund, CMEA Ventures VIII, closed in 2007 with a capital commitment of $300 million. Throughout its active investment period, CMEA Capital built a diversified portfolio, achieving notable exits such as Nuance Communications, a leader in speech recognition and AI. The firm's investment strategy often involved leading rounds and providing significant capital infusions to its portfolio companies.

Historically, CMEA Capital's typical initial investment size ranged from approximately $5 million to $10 million, with the potential for follow-on investments as companies progressed. This approach allowed them to take meaningful stakes in promising ventures. However, CMEA Capital is no longer an active investor in new companies. The firm has largely wound down its operations over the past decade, with its last recorded investment occurring in 2011, making it a historical entity in the venture capital landscape rather than a current participant.

Investor Profile

CMEA Capital has backed more than 96 startups, with 0 new investments in the last 12 months alone. The firm has led 19 rounds, about 20% of its total and boasts 41 exits across its portfolio.

Investment Focus Highlights

  • Concentrates on Series C, Series B, Series A rounds (top funding stages).
  • Majority of deals are located in United States, United Kingdom.
  • Strong thematic focus on Software, Biotechnology, Health Care.
  • Typical check size: $5M – $10M.

Stage Focus

  • Series C (23%)
  • Series B (21%)
  • Series A (20%)
  • Series D (14%)
  • Series Unknown (13%)
  • Series E (4%)
  • Seed (3%)
  • Angel (1%)
  • Debt Financing (1%)
  • Series G (1%)

Country Focus

  • United States (99%)
  • United Kingdom (1%)

Industry Focus

  • Software
  • Biotechnology
  • Health Care
  • Enterprise Software
  • Manufacturing
  • Energy
  • Pharmaceutical
  • Biopharma
  • Mobile
  • Internet
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does CMEA Capital frequently co-invest with?

Sofinnova Investments
North America, California, United States, Menlo Park
Co-Investments: 5
Novartis Venture Fund
Europe, Basel-Stadt, Switzerland, Basel
Co-Investments: 5
Trident Capital
North America, California, United States, Palo Alto
Co-Investments: 4
Google Ventures
North America, California, United States, Mountain View
Co-Investments: 5
New Enterprise Associates
North America, California, United States, Menlo Park
Co-Investments: 6
U.S. Venture Partners
North America, California, United States, Menlo Park
Co-Investments: 13
AgeChem Venture Fund
North America, Quebec, Canada, Montréal
Co-Investments: 3
Maverick Ventures
North America, California, United States, San Francisco
Co-Investments: 4
Redpoint
North America, California, United States, Menlo Park
Co-Investments: 6
ARCH Venture Partners
North America, Illinois, United States, Chicago
Co-Investments: 3

Which angels does CMEA Capital often collaborate with?

RM
North America, California, United States, San Francisco
Shared Deals: 1
MW
North America, California, United States, Los Gatos
Shared Deals: 1
RC
North America, California, United States, San Francisco
Shared Deals: 2
JS
North America, California, United States, San Francisco
Shared Deals: 1
OL
North America, California, United States
Shared Deals: 1
AA
North America, California, United States, San Francisco
Shared Deals: 1
GY
North America, California, United States, San Francisco
Shared Deals: 1
BL
North America, California, United States, Menlo Park
Shared Deals: 1
NR
North America, California, United States, San Francisco
Shared Deals: 1
David Wu
North America, California, United States, San Francisco
Shared Deals: 1

What are some of recent deals done by CMEA Capital?

VYNE Therapeutics

Menlo Park, California, United States

VYNE Therapeutics is a clinical late-stage biopharmaceutical company developing treatments associated with dermatologic conditions.

Health CarePharmaceuticalTherapeutics
Series AMay 1, 2015
Amount Raised: $14,300,000
Cnano Technology

Santa Clara, California, United States

Cnano Technology is dedicated to the production of carbon nanotubes and application of advanced energy.

EnergyManufacturingNanotechnology
Series BApr 20, 2015
Amount Raised: $15,000,000
Jobvite

Indianapolis, Indiana, United States

Jobvite provides end-to-end talent acquisition software and services that increase recruiting quality, speed, and cost-effectiveness.

AnalyticsHuman ResourcesRecruitingSaaSSocial MediaSoftware
Series DOct 7, 2014
Amount Raised: $25,000,000
Sorbent Therapeutics

Sunnyvale, California, United States

Sorbent Therapeutics develops fluid-retaining polymers for kidney disease therapeutics.

BiopharmaBiotechnologyPharmaceutical
Series DMay 15, 2014
Amount Raised: $6,500,000
Arcadia Biosciences

Davis, California, United States

Arcadia Biosciences is an agricultural technology company developing products that benefit the environment and human health.

AgricultureBiotechnologyDietary SupplementsHealth Care
Series DMay 8, 2014
Amount Raised: $33,000,000
Neos Therapeutics

Grand Prairie, Texas, United States

Neos Therapeutics is an oral drug delivery company developing controlled time-release technologies.

BiotechnologyLife ScienceMedicalTherapeutics
Series CMar 4, 2014
Amount Raised: $15,500,000
Auspex Pharmaceuticals

La Jolla, California, United States

Auspex Pharmaceuticals is a deuteration company developing therapeutics for depressive disorders.

BiotechnologyHealth CarePharmaceutical
Series EJan 8, 2014
Amount Raised: $20,000,000
MediaSpike

Mountain View, California, United States

MediaSpike provides a monetization platform for social and mobile games.

AdvertisingAndroidInternetiOSMobileSoftware
Series ANov 4, 2013
Amount Raised: $5,200,000
Mojo Networks

Mountain View, California, United States

Mojo Networks develops a unified cloud managed WiFi offering robust access, security and engagement capabilities for enterprises.

Enterprise SoftwareSaaSSecuritySoftwareWireless
Series DJul 15, 2013
Amount Raised: $10,000,000
Spitfire Pharma

South San Francisco, California, United States

Spitfire Pharma offers drug development and research services that improve the pharmaceutical properties of peptide drugs.

BiotechnologyClinical TrialsPharmaceutical
Series UnknownApr 1, 2013
Amount Raised: $500,000